Jonathan Eucker, MD
Obstetrics & Gynecology · Poland, OHNPI 1417952276
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $44,801 of the $49,979 with a category attached, or 89.6%. Organon accounts for 68.6% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2021 at $12,743 and has fallen 95.8% since, to $540 in 2025. Among obstetrics & gynecology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 252 payments — averaging $198.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$34K
- Merck$12K
- Mayne Pharma Commercial LLC$632
- AbbVie$593
- Amgen$453
- Astellas Pharma US Inc$407
- plus $1K from 17 others
What the payments were for
- Speaking & faculty fees$44,80190%
- Travel & lodging$1,0522%
- Food & beverage$3,8718%
- Education$2551%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 73 | $34,305 |
| Merck | 22 | $12,312 |
| Mayne Pharma Commercial LLC | 29 | $632 |
| AbbVie(2 entities) | 26 | $593 |
| Amgen | 17 | $453 |
| Astellas Pharma US Inc | 15 | $407 |
| Sumitomo Pharma America, Inc. | 15 | $260 |
| Myovant Sciences Inc. | 8 | $172 |
| Therapeuticsmd, Inc. | 8 | $122 |
| Pfizer | 6 | $109 |
| Millicent US Inc | 4 | $99 |
| Hologic Sales And Service, LLC | 5 | $87 |
| Agile Therapeutics, Inc. | 5 | $86 |
| Bayer | 3 | $71 |
| Evofem Biosciences, Inc. | 3 | $51 |
| Duchesnay USA Incorporated | 2 | $48 |
| Avion Pharmaceuticals | 2 | $34 |
| Mylan Pharmaceuticals Inc. | 2 | $33 |
| Lupin Inc. | 2 | $30 |
| Exeltis, USA Inc. | 2 | $29 |
| Exact Sciences | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $13 |
| Covidien LP | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$49,979 in reported general payments places this provider in the 95th percentile of 1,376 obstetrics & gynecology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 145 | $14,269 |
| PremarinEstrogens, Conjugated | 26 | $11,262 |
| ImvexxyEstradiol | 28 | $6,721 |
| Alendronate Sodium | 221 | $4,222 |
| Raloxifene Hcl | 24 | $1,134 |
| ValacyclovirValacyclovir Hcl | 35 | $1,012 |
| Clobetasol Propionate | 18 | $672 |
| Ibandronate Sodium | 22 | $524 |
| Medroxyprogesterone Acetate | 58 | $463 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 15 | $401 |
| Metronidazole | 12 | $226 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 20 | $173 |
| Fluconazole | 34 | $138 |
| Clotrimazole | 11 | $82 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $53 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $109 | $11,26226 claims |
| Therapeuticsmd, Inc.Imvexxy | $122 | $6,72128 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,376 obstetrics & gynecology providers in Ohio.
Other obstetrics & gynecology in Poland
- Samir AhujaMentor$430K
- Burton BrodskySylvania$202K
- Sandor MecsSteubenville$190K
- David SchwartzCincinnati$169K
- Erin OlahColumbus$97K
- David PortmanColumbus$94K
- Anita SomaniColumbus$93K
- Lorie Thomas-SchultzFindlay$92K
- Oluwatosin GojeCleveland$81K
- Gerard ReillyCincinnati$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.